Health care stocks were flat to higher pre-bell Tuesday as the iShares Biotechnology ETF (IBB) was flat and the Health Care Select Sector SPDR Fund (XLV) was up 0.2%.
Sangamo Therapeutics (SGMO) shares fell past 52% after the company said it will regain full development and commercialization rights for giroctocogene fitelparvovec as Pfizer (PFE) decided to terminate the collaboration and licensing agreement for the prospective hemophilia A gene therapy.
Corcept Therapeutics (CORT) shares rose by more than 5% after the company said it filed a new drug application to the US Food and Drug Administration for relacorilant to treat patients with endogenous hypercortisolism.
Acadia Pharmaceuticals (ACAD) is set to join the S&P SmallCap 600 index on Jan. 3, replacing Independent Bank Group (IBTX), S&P Dow Jones Indices said. Acadia Pharmaceuticals shares were up over 8% premarket.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.